Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 8 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

13%

1 trials in Phase 3/4

Results Transparency

13%

1 of 8 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A

7(87.5%)

Phase 4

1(12.5%)

8Total

N/A(7)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT03664167Not ApplicableCompleted

Weight Loss for Obese Individuals With Gout

Role: collaborator

NCT02144597Not ApplicableCompleted

Low-calorie Diet and Body Composition Prior to Roux-en-Y Gastric Bypass

Role: collaborator

NCT02910154Not ApplicableCompleted

Comprehensive Treatment of Angina in Women With Microvascular Dysfunction

Role: collaborator

NCT02905864Phase 4Completed

Liraglutide 3 mg for Knee Osteoarthritis

Role: collaborator

NCT00938808Not ApplicableCompleted

Long-term Intervention With Weight Loss in Patients With Concomitant Obesity and Knee Osteoarthritis. The LIGHT Study

Role: collaborator

NCT01469403Not ApplicableCompleted

Weight Loss Intervention Before Total Knee Replacement

Role: collaborator

NCT00939679Not ApplicableCompleted

Effect of Gastric Bypass Surgery on Energy Metabolism

Role: collaborator

NCT00655941Not ApplicableCompleted

Influence of Weight Loss or Exercise on Cartilage in Obese Knee Osteoarthritis Patients

Role: collaborator

All 8 trials loaded